METHOD FOR PREDICTING TREATMENT EFFECTS OF EGFR INHIBITOR IN GLIOBLASTOMA

摘要

The present invention relates to a method for predicting an effectiveness of a treatment effect of a subject with respect to an epidermal growth factor receptor inhibitor. More specifically, when an EGFR copy number is measured in DNA extracted from a subject through a method based on a new generation sequencing (NGS) scheme, it is clarified that sensitivity with respect to a treatment effect of an EGFR inhibitor is significantly high according to the EGFR copy number. Accordingly, the method based on a new generation sequencing (NGS) scheme may be useful as a method for predicting an effectiveness of a treatment effect of a subject with respect to an EGFR inhibitor.